Author:
Hucke Friederike I. L.,Bugert Joachim J.
Abstract
Chikungunya virus (CHIKV) is the causative agent of chikungunya fever (CHIKF) and is categorized as a(n) (re)emerging arbovirus. CHIKV has repeatedly been responsible for outbreaks that caused serious economic and public health problems in the affected countries. To date, no vaccine or specific antiviral therapies are available. This review gives a summary on current antivirals that have been investigated as potential therapeutics against CHIKF. The mode of action as well as possible compound targets (viral and host targets) are being addressed. This review hopes to provide critical information on the in vitro efficacies of various compounds and might help researchers in their considerations for future experiments.
Subject
Public Health, Environmental and Occupational Health
Reference215 articles.
1. Chikungunya virus: epidemiology, replication, disease mechanisms, and prospective intervention strategies;Silva;J Clin Invest.,2017
2. An epidemic of virus disease in Southern province, tanganyika territory, in 1952-53. I. clinical features;Robinson;Trans Roy Soc Trop Med Hygiene.,1955
3. Control)EECfDPa
Autochthonous Transmission of Chikungunya Virus in EU/EEA, 2007–2020.2020
4. ControlEuCfDPa
Chikungunya Worldwide Overview: Geographical Distribution of Chikungunya Cases Reported Worldwide.2020
5. Epidemiology of Chikungunya infection on Reunion Island, Mayotte, and neighboring countries;Renault;Med Mal Infect.,2012
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献